ISRG Earnings Prediction
The chart below shows how ISRG performed 10 days before and after its earnings report, based on data from the past quarters. Typically, ISRG sees a -0.84% change in stock price 10 days leading up to the earnings, and a +4.67% change 10 days following the report. On the earnings day itself, the stock moves by +0.03%. This data can give you a slight idea of what to expect for the next quarter's release.
ISRG Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
2.41B
25.16%
18.42%
Gross Margin
68.04%
2.72%
0.93%
Operating Margin
30.93%
31.73%
9.10%
Net Margin
28.51%
-9.98%
1.82%
EPS
1.88
11.24%
20.51%
No Data Available
ISRG Earnings Analysis
Intuitive Surgical Inc Corporation (ISRG.O) Earnings Conference Call
Positive
Procedure Growth Highlights: Procedure growth for the full year was 17%, with notable strength in general surgery in the U.S. and strong performance in international markets including the U.K., Ireland, Japan, and Germany.
2024 Revenue Increase: Total revenue for 2024 reached $8.4 billion, representing a 17% increase over 2023, with 84% of this revenue being recurring.
Net Income Growth: Net income grew by 29% in 2024 compared to 2023, reflecting strong operational performance and effective cost management.
Revenue and Margin Growth: In Q4, revenue increased by 25% year-over-year, driven by a higher purchase mix of systems and strong demand for da Vinci 5, resulting in a pro forma operating margin of 38%.
ION Procedures and Systems Growth: ION procedures grew by 70% year-over-year, with 28,000 procedures performed in Q4, and the installed base of ION systems increased by 51% to 805 systems.
Negative
Bariatric Procedures Decline: Bariatric procedures fell modestly for the full year 2024 given the rise in GLP-one medications, indicating a decline in a key segment of the business.
China Procedure Growth Trends: Procedure growth in China was slightly below the corporate average, reflecting a continuation of the dynamics described on previous calls, which may hinder overall growth.
Healthcare Capital Spending Impact: Placements in the U.K. and Germany continue to be impacted by ongoing government budget pressures affecting healthcare capital spending, limiting expansion opportunities.
Rising Operating Expenses: Operating expenses increased 9% in Q4 compared to last year, driven by increased headcount, higher variable compensation, and increased legal expenses, indicating rising costs that could affect profitability.
Gross Profit Margin Decline: Pro forma gross profit margin is expected to decline to a range of 67% to 68% in 2025, down from 69.1% in 2024, primarily due to higher depreciation expenses and a product mix that includes lower-margin products.
ISRG FAQs
How does ISRG typically perform around its earnings report dates?
Is Earnings call transcript: Intuitive Surgical beats Q4 2024 forecasts, stock dips positive or negative?
How can historical earnings data help predict future stock performance?
ISRG Earning Call Sentiment
Earnings call transcript: Intuitive Surgical beats Q4 2024 forecasts, stock dips
ISRG.O
-1.81%Positive
The earnings call reveals strong financial performance with a significant EPS increase, robust system placements, and impressive procedure growth. The company raised its procedure growth forecast and maintained a high gross profit margin. Although there are concerns about future margins and unclear management responses, the overall sentiment from the earnings call is positive. Additionally, the optimistic guidance and strong financial metrics outweigh the potential negatives, suggesting a likely positive stock price movement in the short term.